DocDollars

Capsovision, Inc.

CA · United States · Reporting entity ID 100000291839

Total reported 2019–2025
$13.2M
#421 of 2,960 reporting companies — 0% of all reported industry payments
$4.80M in general payments across 2,575 records, plus $7.95M in research funding across 318 records.

How it breaks down

General payments $4,803,184
Research funding $7,952,461
Ownership & investment $483,485

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Capsovision, Inc. reported $13.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #421 of 2,960 reporting companies. 60% of that was research funding and 40% general payments such as consulting, speaking, food and travel. 2,575 general payment records and 318 research records were filed.

Common questions about Capsovision, Inc.

How much has Capsovision, Inc. paid US doctors?

Capsovision, Inc. reported $13,239,130 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,803,184 in general payments, $7,952,461 in research funding and $483,485 in ownership and investment interests.

How does Capsovision, Inc. rank among drug and device companies?

It ranks #421 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Capsovision, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.